Back to resources

Resources

Displaying 1 - 8 of 35

Conferences and Capital The 2026 Workforce Shift
The Restart Nobody AnnouncedProgrammes come back online well before anyone publishes a press...

By Barrington James July 27th, 2026
Biotechnology
Securing Interim Clinical Leadership During a Critical Post-Funding Scale-Up
A venture-backed European biotechnology company in the respiratory disease space had just cl...

By Bobby Coxon July 2nd, 2026
Company News
Barrington James Appoints Alex Smith as Independent Director
London, UK — Barrington James is delighted to announce the appointment of Alex Smith as...

By Barrington James May 13th, 2026
Introducing Our Contractor Hub: Life Sciences Contract Recruitment
Some hiring problems don’t wait for a permanent search to finish.Your Phase II has just acce...

By Barrington James May 5th, 2026
Biotechnology
Securing CFO leadership with High-Growth Fundraising Experience in a Deep-Tech Market.
Barrington James partnered with an established Canadian deep-technology company to deliver a...

By Adam Bloomfield April 13th, 2026
Biotechnology
Why the Latest IPO Wave Won’t Be Won on Science Alone.
IPO activity does more than unlock capitalIn the last cycle, the path to public markets was ...

By Barrington James March 20th, 2026
Pharmaceutical, Biotechnology
Celebrating Women in Life Sciences: Driving Discovery, Innovation and Change
Scientific progress has always depended on bold ideas, but also on the people courageous eno...

By Barrington James March 8th, 2026
The Diversity Gap in Life Sciences: Progress, Pressure, and the Talent Challenge Companies Can’t Ignore
The life sciences industry exists to solve some of the world’s most complex problems. ...

By Barrington James March 6th, 2026